5/25/2010

Novo Nordisk filed a patent-infringement lawsuit against Lupin to block the latter's generic version of PrandiMet, a medicine to reduce blood glucose in Type 2 diabetics. Lupin recently applied for FDA approval to market 500 milligram/1 milligram and 500 milligram/2 milligram formulations of the drug.

Related Summaries